EPS Bio Technology Corp. (TPEX:4183)
Taiwan
· Delayed Price · Currency is TWD 16.25
+0.15 (0.93%)
Mar 6, 2026, 11:46 AM CST
EPS Bio Technology Revenue
EPS Bio Technology had revenue of 130.57M TWD in the quarter ending September 30, 2025, with 26.96% growth. This brings the company's revenue in the last twelve months to 497.19M, up 2.51% year-over-year. In the year 2024, EPS Bio Technology had annual revenue of 451.08M, down -4.06%.
Revenue (ttm)
497.19M
Revenue Growth
+2.51%
P/S Ratio
0.78
Revenue / Employee
4.56M
Employees
109
Market Cap
386.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 451.08M | -19.08M | -4.06% |
| Dec 31, 2023 | 470.17M | 6.72M | 1.45% |
| Dec 31, 2022 | 463.45M | -16.83M | -3.50% |
| Dec 31, 2021 | 480.28M | 2.68M | 0.56% |
| Dec 31, 2020 | 477.60M | 18.25M | 3.97% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Taiwan Advanced Nanotech | 172.11M |
| Health & Life | 441.84M |
| iXensor | 24.59M |
| PlexBio | 153.06M |
| Radiant Innovation | 413.06M |
| AmCad BioMed | 30.44M |
| S&S Healthcare Holding | 205.64M |
| Wiltrom | 311.77M |